EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MicroPort CardioFlow Medtech EBITDA Margin % Related Terms
MicroPort CardioFlow Medtech EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:72X0 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, MicroPort CardioFlow Medtech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort CardioFlow Medtech EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MicroPort CardioFlow Medtech's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort CardioFlow Medtech (FRA:72X0) has a EBITDA Margin % of -67.92% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MicroPort CardioFlow Medtech and its competitors. According to the industry distribution chart, MicroPort CardioFlow Medtech ranks #602 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 73.8%.
Is MicroPort CardioFlow Medtech's EBITDA Margin % too high?
MicroPort CardioFlow Medtech's current EBITDA Margin % is -67.92%. Based on the distribution chart, MicroPort CardioFlow Medtech ranks #602 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, MicroPort CardioFlow Medtech has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort CardioFlow Medtech's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort CardioFlow Medtech ranks #602 out of 816 companies for EBITDA Margin %. This places MicroPort CardioFlow Medtech in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MicroPort CardioFlow Medtech and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort CardioFlow Medtech's current EBITDA Margin % is -67.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort CardioFlow Medtech stock overvalued right now?
Based on GuruFocus' analysis, MicroPort CardioFlow Medtech (FRA:72X0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.61, compared to a current price of €0.12 — trading 80.3% below its estimated fair value. The current EBITDA Margin % is -67.92%. MicroPort CardioFlow Medtech's overall GF Score™ is 35/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MicroPort CardioFlow Medtech (FRA:72X0), the current EBITDA Margin % is -67.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort CardioFlow Medtech (FRA:72X0) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort CardioFlow Medtech stock appears to be undervalued.
The current stock price of €0.12 is trading 80.3% below its estimated GF Value™ of €0.61.
GuruFocus considers MicroPort CardioFlow Medtech to be Possible Value Trap.
Key valuation signals for FRA:72X0:
EBITDA Margin %: -67.92%
GF Value™: €0.61 vs. price of €0.12 (80.3% below fair value)
No single metric tells the full story. See the FRA:72X0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
35GF Score
Get the complete analysis for FRA:72X0
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:72X0 has been successfully added to your 
